Ann: Half Year Accounts 31 December 2020, page-14

Been some consistent buying the past few weeks - granted on fairly low turnover. Selling depth seemingly dried up. JCS will be better served with a higher shareprice - should see increasing liquidity depth and turnover which in turn will attract a few more investors.

Riyo has huge potential, foundation has been laid, the Epicor tie in essentially de-risked the entire product. For it to be endorsed by a big operator like that, it shows the product offering is world class. Just a matter of time before the customers and revenues flow in!


all IMO , DYOR etc...